The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
DNA Damage Signaling and p53-dependent Senescence after Prolonged β-Interferon Stimulation
Open accessAbstract
Interferons are cytokines with potent antiviral and antiproliferative activities. We report that although a transient exposure to β-interferon induces a reversible cell cycle arrest, a sustained treatment triggers a p53-dependent senescence program. β-Interferon switched on p53 in two steps. First, it induced the acetylation of p53 at lysine 320 and its dephosphorylation at serine 392 but not p53 activity. Later on, it triggered a DNA signaling pathway, the phosphorylation of p53 at serine 15 and its transcriptional activity. In agreement, β-interferon–treated cells accumulated γ-H2AX foci and phosphorylated forms of ATM and CHK2. The DNA damage signaling pathway was activated by an increase in reactive oxygen species (ROS) induced by interferon and was inhibited by the antioxidant N-acetyl cysteine. More important, RNA interference against ATM inhibited p53 phosphorylation at serine 15, p53 activity and senescence in response to β-interferon. β-Interferon–induced senescence was more efficient in cells expressing either, p53, or constitutive allele of ERK2 or RasV12. Hence, β-interferon–induced senescence targets preferentially cells with premalignant changes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This includes chronic signaling by anti-proliferative cytokines that increase cellular oxidative stress and potentiate senescence”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [60]
In the citing paper
“Indeed, β-interferons increase ROS production, leading to DNA damage and p53 activation [273,274].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [274]
In the citing paper
“In response to senesce-inducing stimuli, senescent cells produce, in a cGAS-dependent manner, type I interferons that have pro-senescence and anti-proliferative activities.”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [274]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“Expression of oncogenic ras in normal human fibroblasts IMR90 triggers a permanent cell cycle arrest with features of cellular senescence and expression of some interferon responsive genes (Serrano et al., 1997; Ferbeyre et al., 2000).”
BackgroundMitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017 · cited 1×
“Viruses in turn, have evolved proteins that interfere with the interferon pathway and with senescence regulators such as the tumor suppressors PML, p53 or RB (Whyte et al., 1988; Dyson et al., 1989; Scheffner et al., 1990; Gutch and Reich, 1991; Barnard and McMillan, 1999; Everett, 2001).”
BackgroundA DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 2×
“For example, short telomeres or DNA damage activate the senescence program through the checkpoint proteins ATM, ATR, CHK1, and CHK2 (d’Adda di Fagagna et al., 2003; Herbig et al., 2004; Zglinicki et al., 2005).”
BackgroundRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 2×
“typical of senescent cells ( Narita et al., 2003 ) (Supplementary figure 1D).”
BackgroundActivation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
DNA Damage Foci at Dysfunctional Telomeres
Takai, H., Smogorzewska, A., & de Lange, T. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00542-6 · Cited by 1,409
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Herbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J. (2001) · Nature · doi:10.1038/35071124 · Cited by 1,085
Mitochondria, oxygen free radicals, disease and ageing
Raha, S., & Robinson, B. H. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01674-1 · Cited by 1,066 · cited 2×
“, 2003), which in general increase the rate of superoxide generation by the mitochondria (Raha and Robinson, 2000).”
BackgroundLin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.19.3008 · Cited by 945
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P., et al. (2000) · Nature · doi:10.1038/35018127 · Cited by 847
Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T., Honda, K., et al. (2003) · Nature · doi:10.1038/nature01850 · Cited by 847
Mitochondrial threshold effects
ROSSIGNOL, R., FAUSTIN, B., ROCHER, C., MALGAT, M., MAZAT, J.-P., & LETELLIER, T. (2003) · Biochemical Journal · doi:10.1042/bj20021594 · Cited by 798
Barlev, N. A., Liu, L., Chehab, N. H., Mansfield, K., Harris, K. G., Halazonetis, T. D., & Berger, S. L. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00414-2 · Cited by 710 · cited 1×
“This modification may contribute to p53 activation by increasing the recruitment of histone acetyl transferases to p53-dependent promoters (Barlev et al., 2001).”
BackgroundRas Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species
Lee, A. C., Fenster, B. E., Ito, H., Takeda, K., Bae, N. S., Hirai, T., Yu, Z.-X., Ferrans, V. J., Howard, B. H., & Finkel, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7936 · Cited by 691 · cited 2×
“For example, oncogenes may damage DNA by inducing the production of ROS (Lee et al., 1999; Benhar et al., 2002; Catalano et al., 2005) and therefore they may sensitize cells to -interferon as shown here.”
BackgroundROS, stress‐activated kinases and stress signaling in cancer
Benhar, M., Engelberg, D., & Levitzki, A. (2002) · The EMBO Reports · doi:10.1093/embo-reports/kvf094 · Cited by 600 · cited 13×
“To prove the role of ROS in the DNA damage signaling pathway activated by -interferon, we treated the cells with N-acetyl-cysteine (NAC).”
BackgroundInfluentialPML is induced by oncogenic ras and promotes premature senescence
Ferbeyre, G., de Stanchina, E., Querido, E., Baptiste, N., Prives, C., & Lowe, S. W. (2000) · Genes & Development · doi:10.1101/gad.14.16.2015 · Cited by 536 · cited 12×
“Expression of oncogenic ras in normal human fibroblasts IMR90 triggers a permanent cell cycle arrest with features of cellular senescence and expression of some interferon responsive genes (Serrano et al., 1997; Ferbeyre et al., 2000).”
BackgroundMethodInfluentialSelf-citationHallmarks of senescence in carcinogenesis and cancer therapy
Shay, J. W., & Roninson, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207518 · Cited by 502
Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491 · cited 3×
“tion factor IRF1 (Tanaka et al., 1994).”
BackgroundInfluentialTaniguchi, T., & Takaoka, A. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00305-3 · Cited by 482
Human cell senescence as a DNA damage response
Zglinicki, T. V., Saretzki, G., Ladhoff, J., Fagagna, F. D. D., & Jackson, S. P. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.09.034 · Cited by 419 · cited 1×
“For example, short telomeres or DNA damage activate the senescence program through the checkpoint proteins ATM, ATR, CHK1, and CHK2 (d’Adda di Fagagna et al., 2003; Herbig et al., 2004; Zglinicki et al., 2005).”
BackgroundWang, W., Chen, J. X., Liao, R., Deng, Q., Zhou, J. J., Huang, S., & Sun, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3389-3403.2002 · Cited by 376
Hypoxia Links ATR and p53 through Replication Arrest
Hammond, E. M., Denko, N. C., Dorie, M. J., Abraham, R. T., & Giaccia, A. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1834-1843.2002 · Cited by 324
PEA-15 Mediates Cytoplasmic Sequestration of ERK MAP Kinase
Formstecher, E., Ramos, J. W., Fauquet, M., Calderwood, D. A., Hsieh, J.-C., Canton, B., Nguyen, X.-T., Barnier, J.-V., Camonis, J., Ginsberg, M. H., et al. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00035-1 · Cited by 313
PML Is a Direct p53 Target that Modulates p53 Effector Functions
de Stanchina, E., Querido, E., Narita, M., Davuluri, R. V., Pandolfi, P. P., Ferbeyre, G., & Lowe, S. W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00062-0 · Cited by 312
Self-citationOncogenic ras and p53 Cooperate To Induce Cellular Senescence
Ferbeyre, G., de Stanchina, E., Lin, A. W., Querido, E., McCurrach, M. E., Hannon, G. J., & Lowe, S. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3497-3508.2002 · Cited by 290
Self-citationStadler, M., Chelbi‐Alix, M. K., Koken, M. H. M., Venturini, L., Lee, C., Saı̈b, A., Quignon, F., Pelicano, L., Guillemin, M.-C., & Schindler, C. (1995) · PubMed · Cited by 266
DNA viruses and viral proteins that interact with PML nuclear bodies
Everett, R. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204759 · Cited by 246
Deconstructing PML-induced premature senescence
Bischof, O. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf341 · Cited by 233
The acute promyelocytic leukaemia-associated PML gene is induced by interferon.
Lavau, C., Marchio, A., Fagioli, M., Jansen, J. H., Falini, B., Lebon, P., Grosveld, F. G., Pandolfi, P. P., Pelicci, P. G., & Dejean, A. (1995) · PubMed · Cited by 228
The Human Papillomavirus E7 Oncoprotein Abrogates Signaling Mediated by Interferon-α
Barnard, P., & McMillan, N. A. J. (1999) · Virology · doi:10.1006/viro.1999.9771 · Cited by 227
Resnitzky, D., Yarden, A., Zipori, D., & Kimchi, A. (1986) · Cell · doi:10.1016/0092-8674(86)90857-3 · Cited by 195
Regulation of cellular response to oncogenic and oxidative stress by Seladin-1
Wu, C., Miloslavskaya, I., Demontis, S., Maestro, R., & Galaktionov, K. (2004) · Nature · doi:10.1038/nature03173 · Cited by 192
Webley, K., Bond, J. A., Jones, C. J., Blaydes, J. P., Craig, A., Hupp, T., & Wynford-Thomas, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2803-2808.2000 · Cited by 192
Kudoh, A., Fujita, M., Zhang, L., Shirata, N., Daikoku, T., Sugaya, Y., Isomura, H., Nishiyama, Y., & Tsurumi, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411405200 · Cited by 190
Deng, Q., Liao, R., Wu, B.-L., & Sun, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308644200 · Cited by 181
Senescent fibroblasts resist apoptosis by downregulating caspase-3.
Marcotte, R., Lacelle, C., & Wang, E. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.07.007 · Cited by 159 · cited 2×
“S389A have a reduced apoptotic response (Bruins et al., 2004) as seen in senescent cells (Marcotte et al., 2004), which also have p53 dephosphorylated at serine 392 (Webley et al., 2000).”
BackgroundHottiger, M. O., Felzien, L. K., & Nabel, G. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3124 · Cited by 137
5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation
Catalano, A., Rodilossi, S., Caprari, P., Coppola, V., & Procopio, A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600502 · Cited by 123 · cited 14×
“To prove the role of ROS in the DNA damage signaling pathway activated by -interferon, we treated the cells with N-acetyl-cysteine (NAC).”
BackgroundInfluentialIncreased Sensitivity to UV Radiation in Mice with a p53 Point Mutation at Ser389
Bruins, W., Zwart, E., Attardi, L. D., Iwakuma, T., Hoogervorst, E. M., Beems, R. B., Miranda, B., van Oostrom, C. T. M., van den Berg, J., van den Aardweg, G. J., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.8884-8894.2004 · Cited by 121
Mallette, F. A., Goumard, S., Gaumont‐Leclerc, M., Moiseeva, O. V., & Ferbeyre, G. (2004) · Oncogene · doi:10.1038/sj.onc.1206886 · Cited by 119
Self-citationXin, H., Curry, J. L., Johnstone, R. W., Nickoloff, B. J., & Choubey, D. (2003) · Oncogene · doi:10.1038/sj.onc.1206754 · Cited by 117
DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site
Blaydes, J. P., & Hupp, T. R. (1998) · Oncogene · doi:10.1038/sj.onc.1202014 · Cited by 109
Hypoxia attenuates the p53 response to cellular damage
Achison, M., & Hupp, T. R. (2003) · Oncogene · doi:10.1038/sj.onc.1206434 · Cited by 107
Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene.
Gutch, M. J., & Reich, N. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.7913 · Cited by 106
Role of IFI 16 in cellular senescence of human fibroblasts
Xin, H., Pereira‐Smith, O. M., & Choubey, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207836 · Cited by 81
Senescence-like changes induced by hydroxyurea in human diploid fibroblasts
Yeo, E., Hwang, Y. C., Kang, C., Kim, I.-H., Kim, D., Parka, J.-H., Choy, H. E., Park, W., & Park, S. C. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00108-x · Cited by 80
Roy, F. L., Bisbal, C., Silhol, M., Martinand‐Mari, C., Lebleu, B., & Salehzada, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107482200 · Cited by 78
Harvat, B. L., & Jetten, A. M. (1996) · PubMed · Cited by 76
Constitutive Activation of Extracellular Signal-regulated Kinase 2 by Synergistic Point Mutations
Emrick, M. A., Hoofnagle, A. N., Miller, A. S., Eyck, L. F. T., & Ahn, N. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107708200 · Cited by 70
Inhibition of Mitochondrial Function by Interferon
Lewis, J. A., Huq, A., & Najarro, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13184 · Cited by 67
Lim, I. K., Hong, K. W., Kwak, I. H., Yoon, G., & Park, S. C. (2000) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00167-6 · Cited by 65
Gaumont‐Leclerc, M., Mukhopadhyay, U. K., Goumard, S., & Ferbeyre, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403893200 · Cited by 57
Self-citationMukhopadhyay, U. K., Senderowicz, A. M., & Ferbeyre, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2502 · Cited by 56
Self-citationDirect Evidence That IFN- β Functions as a Tumor-Suppressor Protein
Kaynor, C., Xin, M., Wakefield, J., Barsoum, J., & Qin, X.-Q. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900260442511 · Cited by 49
Interferon Treatments: How to Use an Endogenous System as a Therapeutic Agent
DIANZANI, F. (1992) · Journal of Interferon Research · doi:10.1089/jir.1992.1992.109 · Cited by 47
Expression of Interferon-β is Associated with Growth Arrest of Murine and Human Epidermal Cells
Bielenberg, D. R., McCarty, M. F., Bucana, C. D., Yuspa, S. H., Morgan, D., Arbeit, J. M., Ellis, L. M., Cleary, K. R., & Fidler, I. J. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00566.x · Cited by 46
Modulation of E2F Activity Is Linked to Interferon-induced Growth Suppression of Hematopoietic Cells
Iwase, S., Furukawa, Y., Kikuchi, J., Nagai, M., Terui, Y., Nakamura, M., & Yamada, H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12406 · Cited by 45
Hoogervorst, E. M., Bruins, W., Zwart, E., van Oostrom, C. T. M., van den Aardweg, G. J., Beems, R. B., van den Berg, J., Jacks, T., STEEG, H. V., & de Vries, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4328 · Cited by 41
PML a target of translocations in APL is a regulator of cellular senescence
Ferbeyre, G. (2002) · Leukemia · doi:10.1038/sj.leu.2402722 · Cited by 37
Self-citationModification of serine 392 is a critical event in the regulation of p53 nuclear export and stability
Kim, Y.-Y., Park, B.-J., Kim, D. J., Kim, W.-H., Kim, S., Oh, K.-S., Lim, J.-Y., Kim, J., Park, C., & Park, S.-I. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.014 · Cited by 27
Lou, J., Anderson, S. L., Xing, L., & Rubin, B. Y. (1994) · Journal of Interferon Research · doi:10.1089/jir.1994.14.33 · Cited by 22
Interferon-α repressed telomerase along with G1-accumulation of Daudi cells
Akiyama, M., Iwase, S., Horiguchi‐Yamada, J., Saito, S., Furukawa, Y., Yamada, O., Mizoguchi, H., Ohno, T., & Yamada, H. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00109-3 · Cited by 21
Inagaki, H., Matsushima, Y., Ohshima, M., & Kitagawa, Y. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.263 · Cited by 21
Yarosh, D. B., Scudiero, D. A., Yagi, T., & Day, R. S. (1985) · Carcinogenesis · doi:10.1093/carcin/6.6.883 · Cited by 9
Cited by
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
An epigenetic biomarker of aging for lifespan and healthspan
Levine, M. E., Lu, A. T., Quach, A., Chen, B. H., Assimes, T. L., Bandinelli, S., Hou, L., Baccarelli, A. A., Stewart, J. D., Li, Y., et al. (2018) · Aging · doi:10.18632/aging.101414 · Cited by 3,675
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Metadata
- Authors
- Moiseeva, O., Mallette, F. A., Mukhopadhyay, U. K., Moores, A., & Ferbeyre, G.
- Affiliations
- Université de Montréal (CA)
- Venue
- Molecular Biology of the Cell
- Published
- 2006-04
- Volume
- 17
- Issue
- 4
- Pages
- 1583-1592
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- PMC
- PMC1415317
- OpenAlex
- W2131974830
- Cited by
- 252
- References
- 72
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 10 · 2023: 7 · 2022: 12 · 2021: 14 · 2020: 16 · 2019: 11 · 2018: 17 · 2017: 17 · 2016: 17 · 2015: 13 · 2014: 16 · 2013: 18 · 2012: 10
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular Biology of the Cell (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Research Society
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- interferon-beta, p53, cellular senescence, DNA damage signaling, p53 Ser15 phosphorylation, p53 acetylation, ATM, Chk2, γH2AX foci, reactive oxygen species, N-acetylcysteine, ERK2, RasV12, cell cycle arrest, premalignant cells
- MeSH terms
- Acetylation, Cell Cycle, DNA Damage, DNA-Binding Proteins, Fibroblasts, Histones, Humans, Lysine, Phosphorylation, Serine, Transcription, Genetic, Signal Transduction, Tumor Suppressor Protein p53, Interferon-beta, Cellular Senescence, Protein Serine-Threonine Kinases, Reactive Oxygen Species, Cell Cycle Proteins, Mitogen-Activated Protein Kinase 1, Tumor Suppressor Proteins, RNA Interference, Ataxia Telangiectasia Mutated Proteins, Checkpoint Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.